Merck Opens South Korean Bioprocessing Center With Investment Exceeding €300 Million
Merck opened a bioprocessing center in South Korea after an investment exceeding €300 million.
Related stories
South Korean Shares Fall More Than 5% on AI Doubts
The KOSPI fell more than 5%, with shares set to end the month lower.
M impact | EQUITY | Oct 30, 2026, 02:44 AM UTC
Keytruda SC Quarterly Sales Reach a New Milestone
Quarterly sales of Keytruda SC, which uses Alteogen’s technology, surpassed the stated threshold for the first time.
M impact | EQUITY | Oct 30, 2026, 02:39 AM UTC
闻泰科技 hits limit-up after confidentiality arrangement with Nexperia administrator
China’s Wingtech Technology rose to its daily limit after announcing a confidentiality arrangement with Nexperia’s administrator regarding negotiations.
M impact | EQUITY | Oct 30, 2026, 02:38 AM UTC
Jakarta Stocks Fall 2.2%
M impact | EQUITY | Oct 30, 2026, 02:38 AM UTC
Luxshare Precision shares fall 4.7% in Hong Kong and mainland China
Luxshare Precision’s Hong Kong shares fell as much as 4.7% Friday morning, while its mainland-listed A shares also fell 4.7%. The headline reports slower year-over-year net profit
M impact | EQUITY | Oct 30, 2026, 02:38 AM UTC
Shenghong Technology H Shares Fall 15.1% as Q3 Net Profit Drops More Than Half
Shenghong Technology’s H shares fell as much as 15.1% early Friday after third-quarter net profit fell more than half year over year.
M impact | EQUITY | Oct 30, 2026, 02:34 AM UTC